Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

  67,796,291      
Direct Value   $162,038,028    

Indirect Value

  $374,282,250      
Total Shares   71,480,988      
Total Value   $536,320,277      


Halozyme Therapeutics Inc
 $162,017,406 Alaunos Therapeutics
 $20,621 Halozyme Therapeutics Inc
 $162,017,406 Alaunos Therapeutics
 $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    14   
    0    

     Stock price went up :

    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

Download
  Page 7 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
HALO Halozyme Therapeutics Inc Director   –       •       •   2017-07-24 4 D $0.00 $0 I/I (6,328,853) 0 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-07-31 4 A $21.59 $999,985 I/I 43,850 13,461,314 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-08-11 4 B $18.85 $2,499,981 I/I 132,625 6,782,622 2.64 -
PRPO Precipio Inc 10% Owner   –       –       •   2017-08-28 4 A $0.00 $0 I/I 813,482 271,824 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-08-31 4 A $18.63 $999,974 I/I 53,077 13,471,450 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-09-29 4 A $19.01 $999,966 I/I 51,820 13,481,970 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-10-31 4 A $16.35 $999,991 I/I 56,701 13,494,202 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-11-30 4 A $12.65 $999,988 I/I 77,903 13,508,864 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-12-29 4 A $11.33 $14,686,410 I/I 1,288,632 886,491 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-01-19 4 B $12.50 $12,500,000 I/I 1,000,000 7,782,622 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-01-31 4 A $13.00 $999,981 I/I 69,768 14,749,589 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-02-28 4 A $13.02 $999,985 I/I 74,097 14,764,949 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-03-30 4 A $15.33 $999,979 I/I 60,551 14,777,995 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-04-30 4 A $18.18 $999,984 I/I 51,775 14,788,996 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-05-31 4 A $16.20 $999,976 I/I 61,444 14,801,058 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-27 4 S $17.34 $927,777 I/I (53,505) 3,945,650 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-28 4 S $16.99 $2,181,261 I/I (128,385) 3,869,359 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-06-29 4 A $13.94 $999,987 I/I 63,882 14,815,405 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-29 4 S $16.97 $2,077,654 I/I (122,431) 3,796,606 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-07-03 4 B $13.37 $99,999,992 I/I 7,479,431 15,937,319 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-25 4 S $17.32 $1,799,548 I/I (103,900) 3,734,865 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-26 4 S $17.30 $2,595,000 I/I (150,000) 3,645,729 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-27 4 S $16.90 $826,866 I/I (48,927) 3,616,655 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-07-31 4 A $14.66 $999,982 I/I 65,657 15,950,961 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-08 4 S $17.52 $2,570,499 I/I (146,718) 3,529,470 0 -

  271  Records found
  1   2   3   4   5   6   7  8   9   10   11      
  Page 7 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed